Sirtuin 7 Promotes Glioma Proliferation and Invasion Through Activation of the ERK/STAT3 Signaling Pathway

Oncology Letters - Greece
doi 10.3892/ol.2018.9800
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

TRIM31 Promotes Glioma Proliferation and Invasion Through Activating NF-κB Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

EIF5A1 Promotes Trophoblast Migration and Invasion via ARAF-mediated Activation of the Integrin/Erk Signaling Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Baicalein Inhibits Melanogenesis Through Activation of the ERK Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2010English

Downregulation of CKS1B Restrains the Proliferation, Migration, Invasion and Angiogenesis of Retinoblastoma Cells Through the MEK/ERK Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2019English

BHLHE41 Promotes U87 and U251 Cell Proliferation via ERK/cyclinD1 Signaling Pathway

Cancer Management and Research
Oncology
2019English

Electroacupuncture Promotes Neural Cell Proliferation in Vivo Through Activation of the ERK1/2 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2014English

REG3A Overexpression Suppresses Gastric Cancer Cell Invasion, Proliferation and Promotes Apoptosis Through PI3K/Akt Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

TROP2 Promotes the Proliferation and Metastasis of Glioblastoma Cells by Activating the JAK2/STAT3 Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

LncRNA AWPPH Promotes the Proliferation, Migration and Invasion of Ovarian Carcinoma Cells via Activation of the WNT/Β‑catenin Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy